These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 15661074)
1. Functional promoter upstream p53 regulatory sequence of IGFBP3 that is silenced by tumor specific methylation. Hanafusa T; Shinji T; Shiraha H; Nouso K; Iwasaki Y; Yumoto E; Ono T; Koide N BMC Cancer; 2005 Jan; 5():9. PubMed ID: 15661074 [TBL] [Abstract][Full Text] [Related]
2. Silencing of caspase-8 in murine hepatocellular carcinomas is mediated via methylation of an essential promoter element. Liedtke C; Zschemisch NH; Cohrs A; Roskams T; Borlak J; Manns MP; Trautwein C Gastroenterology; 2005 Nov; 129(5):1602-15. PubMed ID: 16285959 [TBL] [Abstract][Full Text] [Related]
3. Epigenetic modulation of tumor suppressor CCAAT/enhancer binding protein alpha activity in lung cancer. Tada Y; Brena RM; Hackanson B; Morrison C; Otterson GA; Plass C J Natl Cancer Inst; 2006 Mar; 98(6):396-406. PubMed ID: 16537832 [TBL] [Abstract][Full Text] [Related]
4. Transcriptional repression of the human p53 gene by hepatitis B viral core protein (HBc) in human liver cells. Kwon JA; Rho HM Biol Chem; 2003 Feb; 384(2):203-12. PubMed ID: 12675512 [TBL] [Abstract][Full Text] [Related]
5. Transcriptional down-regulation of IGFBP-3 in human hepatocellular carcinoma cells is mediated by the binding of TIA-1 to its AT-rich element in the 3'-untranslated region. Subramaniam K; Ooi LL; Hui KM Cancer Lett; 2010 Nov; 297(2):259-68. PubMed ID: 20599318 [TBL] [Abstract][Full Text] [Related]
6. Transcription factors Oct-1 and NF-YA regulate the p53-independent induction of the GADD45 following DNA damage. Jin S; Fan F; Fan W; Zhao H; Tong T; Blanck P; Alomo I; Rajasekaran B; Zhan Q Oncogene; 2001 May; 20(21):2683-90. PubMed ID: 11420680 [TBL] [Abstract][Full Text] [Related]
7. Target gene modulation in hepatocellular carcinomas by decreased DNA-binding of p53 mutations. Kubicka S; Trautwein C; Niehof M; Manns M Hepatology; 1997 Apr; 25(4):867-73. PubMed ID: 9096590 [TBL] [Abstract][Full Text] [Related]
8. Aberrant epigenetic modifications in hepatocarcinogenesis induced by hepatitis B virus X protein. Park IY; Sohn BH; Yu E; Suh DJ; Chung YH; Lee JH; Surzycki SJ; Lee YI Gastroenterology; 2007 Apr; 132(4):1476-94. PubMed ID: 17408664 [TBL] [Abstract][Full Text] [Related]
9. p53 involvement in activation of the cytokeratin 8 gene in tumor cell lines. Mukhopadhyay T; Roth JA Anticancer Res; 1996; 16(1):105-12. PubMed ID: 8615594 [TBL] [Abstract][Full Text] [Related]
10. [Interaction of p53 with p53 response element like binding sequence at upstream of hepatitis B virus enhancer I]. Qu JH; Zhu MH; Lin J; Ni CR; Li FM; Zhu Z; Yu GZ Ai Zheng; 2004 May; 23(5):502-7. PubMed ID: 15142443 [TBL] [Abstract][Full Text] [Related]
11. Identification of the p53 family-responsive element in the promoter region of the tumor suppressor gene hypermethylated in cancer 1. Britschgi C; Rizzi M; Grob TJ; Tschan MP; Hügli B; Reddy VA; Andres AC; Torbett BE; Tobler A; Fey MF Oncogene; 2006 Mar; 25(14):2030-9. PubMed ID: 16301995 [TBL] [Abstract][Full Text] [Related]
12. Transcriptional activity and Sp 1/3 transcription factor binding to the P1 promoter sequences of the human AbetaH-J-J locus. Feriotto G; Finotti A; Breveglieri G; Treves S; Zorzato F; Gambari R FEBS J; 2007 Sep; 274(17):4476-90. PubMed ID: 17681019 [TBL] [Abstract][Full Text] [Related]
14. Methylation-associated silencing of death-associated protein kinase gene in laryngeal squamous cell cancer. Kong WJ; Zhang S; Guo C; Zhang S; Wang Y; Zhang D Laryngoscope; 2005 Aug; 115(8):1395-401. PubMed ID: 16094112 [TBL] [Abstract][Full Text] [Related]
15. Sp1/Sp3 and DNA-methylation contribute to basal transcriptional activation of human podoplanin in MG63 versus Saos-2 osteoblastic cells. Hantusch B; Kalt R; Krieger S; Puri C; Kerjaschki D BMC Mol Biol; 2007 Mar; 8():20. PubMed ID: 17343736 [TBL] [Abstract][Full Text] [Related]
16. Regulation of human glucocorticoid receptor gene transcription by Sp1 and p53. Suehiro T; Kaneda T; Ikeda Y; Arii K; Kumon Y; Hashimoto K Mol Cell Endocrinol; 2004 Jul; 222(1-2):33-40. PubMed ID: 15249123 [TBL] [Abstract][Full Text] [Related]
17. Transcriptional regulation of the mouse PNRC2 promoter by the nuclear factor Y (NFY) and E2F1. Zhou D; Masri S; Ye JJ; Chen S Gene; 2005 Nov; 361():89-100. PubMed ID: 16181749 [TBL] [Abstract][Full Text] [Related]
18. IGFBP-3 expression in hepatocellular carcinoma involves abnormalities in TGF-beta and/or Rb signaling pathways. Yumoto E; Nakatsukasa H; Hanafusa T; Yumoto Y; Nouso K; Matsumoto E; Onishi T; Takuma Y; Tanaka H; Fujikawa T; Suzuki M; Uemura M; Shiratori Y Int J Oncol; 2005 Nov; 27(5):1223-30. PubMed ID: 16211216 [TBL] [Abstract][Full Text] [Related]
19. The tumor suppressor gene hypermethylated in cancer 1 is transcriptionally regulated by E2F1. Jenal M; Trinh E; Britschgi C; Britschgi A; Roh V; Vorburger SA; Tobler A; Leprince D; Fey MF; Helin K; Tschan MP Mol Cancer Res; 2009 Jun; 7(6):916-22. PubMed ID: 19491197 [TBL] [Abstract][Full Text] [Related]
20. Activation of Galectin-1 gene in human hepatocellular carcinoma involves methylation-sensitive complex formations at the transcriptional upstream and downstream elements. Kondoh N; Hada A; Ryo A; Shuda M; Arai M; Matsubara O; Kimura F; Wakatsuki T; Yamamoto M Int J Oncol; 2003 Dec; 23(6):1575-83. PubMed ID: 14612929 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]